Lamictal (Lamotrigine) is a medication that was first approved by the FDA in 1994 for the treatment of partial seizures, later in 1998 for the treatment of Lennox-Gastaut syndrome, and again 2003 for the management of bipolar disorder. Specifically, Lamictal is used to prevent and/or treat: focal seizures, tonic-clonic seizures, and acute depressive episodes or …
Lamictal (lamotrigine) is an anticonvulsant medication prescribed for the prophylaxis and/or management of epilepsy and bipolar disorder. Research suggests that Lamictal modifies neurochemistry by: inhibiting voltage-gated sodium channels, blocking various calcium channels (L-type; N-type; P-type), antagonizing sigma and 5-HT3 receptors, upregulating GABA signaling, and suppressing the release of glutamate and aspartate. Through the aforementioned mechanisms …
Lamotrigine is a synthetic phenyltriazine chemical with anticonvulsant and analgesic properties initially sold by GlaxoSmithKline under the brand name Lamictal. It was first approved by the FDA in 1994 for the treatment of partial seizures in adults, and was subsequently approved in 1998 for the management of Lennox-Gastaut syndrome – a severe form of epilepsy …
Lamictal (Lamotrigine) is a drug that is approved for the treatment of epilepsy and bipolar disorder. It works as a sodium channel blocker by inhibiting voltage-sensitive sodium channels. It is also thought to inhibit the release of glutamate at various areas throughout the limbic system. The drug has been found to be neuroprotective and is …